🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Start Date
2023-11-13
Trial ID
NCT05870579
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
This study will assess the relationship between fulvestrant dose and effica...
Status
Completed
Location
Research Site
Start Date
2006-05-30
Trial ID
NCT00313170
Treatments Being Tested
This is a randomized trial for patients with metastatic hormone receptor (H...
Status
Completed
Location
University of Alabama at Birmingham (UAB)
Start Date
2016-03
Trial ID
NCT02632045
Treatments Being Tested
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
The main purpose of this research study is to learn whether the investigati...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2020-10-15
Trial ID
NCT03685331
Treatments Being Tested
This study adopts multicenter/randomized trial design. It plans to enroll p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-30
Trial ID
NCT06941142
Treatments Being Tested
This study is a prospective, single-arm, phase II clinical study for patien...
Status
Unknown
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05577923
Treatments Being Tested
Fulvestrant 500mg in Patients With Advanced Breast Cancer...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2017-10-11
Trial ID
NCT02909361
Treatments Being Tested